Yuan Ji to Immunotherapy, Adoptive
This is a "connection" page, showing publications Yuan Ji has written about Immunotherapy, Adoptive.
Connection Strength
0.613
-
Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials. Clin Cancer Res. 2017 Jan 01; 23(1):13-20.
Score: 0.520
-
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size. J Biopharm Stat. 2012; 22(6):1206-19.
Score: 0.093